Collins Stewart Upgrades Force Protection (FRPT) to Buy; Adjusts 2009-10 Estimates
More News related to FRPT
- Force Protection Appoints Director of Training
- Force Protection Announces Participation at Oppenheimer Conference
- Trading Outlook for Force Protection Inc. Issued by StockPreacher.com
- Notable Analyst Rating Changes 11/10: ADBE, ANN, FRPT, RAX Upgraded; ALU, CPST, PIKE, TRW Downgraded
- FBR Capital Upgrades Force Protection (FRPT) to Market Perform
More News related to Upgrades
- Somaxon Pharmaceuticals (SOMX) Surges Ahead of FDA Action Date
- BioMarin Pharmaceutical (BMRN) Announces FDA Grants Orphan Drug Designation for 3,4-DAP
- FDA Approves Cymbalta (LLY) for Treatment of Generalized Anxiety Disorder
- Eurand N.V. (EURX) Announces Availability of ZENPEP
- Spectrum Pharma (SPPI) Phase 3 Apaziquone Enrollment Complete
Collins Stewart upgrades Force Protection (Nasdaq: FRPT) to Buy. Price target $7
Collins analyst says, "We believe the company has the ability to produce $450 million of ongoing revenues for some time. Given the high operational tempo in Iraq and Afghanistan, we think this lower level of revenues is still some time away. In addition, we believe this revenue has upside opportunities from potential Cheetah sales, the Oceleot entry in the UK's Light Protected Patrol Vehicle (LPPV) program, Force Armor and possible acquisitions...The catalyst for the change is the company's announcement of a cost cutting program to align its expense base with a lower vehicle production outlook. This is a move we have long called for, but the magnitude and timing are bigger and faster than we modeled. We are raising our 2010 EPS estimates, while 2009 falls due to lower than previously modeled margins."
To see more analyst ratings on FRPT Click Here.
Related Categories
UpgradesStocks Mentioned
-0.04Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
